General MedicationsORALStandard
PHYTONADIONE
PHYTONADIONE
Standard Dose
EQ 36GM BASE/VIAL;EQ 4.5GMBASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PHYTONADIONE is listed in Drugs@FDA under application 213336 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PHYTONADIONE Form and strength TABLET;ORAL - EQ 36GM BASE/VIAL;EQ 4.5GMBASE/VIAL Sponsor AGNITIO Submission history Latest submission status date: 2023-10-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview PHYTONADIONE is listed in Drugs@FDA under application 213336 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PHYTONADIONE Form and strength TABLET;ORAL - EQ 36GM BASE/VIAL;EQ 4.5GMBASE/VIAL Sponsor AGNITIO Submission history Latest submission status date: 2023-10-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.